-
1
-
-
0033816299
-
Low-molecular-weight heparin in the treatment of venous thromboembolism
-
Hull RD, Pineo GF. Low-molecular-weight heparin in the treatment of venous thromboembolism. Sem Thromb Hemost 2000; 26 (Suppl 1): 61-7.
-
(2000)
Sem Thromb Hemost
, vol.26
, Issue.SUPPL. 1
, pp. 61-67
-
-
Hull, R.D.1
Pineo, G.F.2
-
2
-
-
0034707642
-
Low-molecular-weight heparin vs. heparin in the treatment of patients with pulmonary embolism
-
Hull RD, Raskob GE, Brant RF, et al. Low-molecular-weight heparin vs. heparin in the treatment of patients with pulmonary embolism. Arch Intern Med 2000; 160: 229-36.
-
(2000)
Arch Intern Med
, vol.160
, pp. 229-236
-
-
Hull, R.D.1
Raskob, G.E.2
Brant, R.F.3
-
3
-
-
0034264161
-
Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
-
Merli GJ. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism. Am J Phys Med Rehabil 2000; 79 (Suppl): S9-S16.
-
(2000)
Am J Phys Med Rehabil
, vol.79
, Issue.SUPPL.
-
-
Merli, G.J.1
-
4
-
-
0032745736
-
Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis
-
Davidson BL. Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis. Sem Thromb Hemost 1999; 25 (Suppl 3): 107-12.
-
(1999)
Sem Thromb Hemost
, vol.25
, Issue.SUPPL. 3
, pp. 107-112
-
-
Davidson, B.L.1
-
5
-
-
0031755859
-
Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis
-
Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Int Angiol 1998; 17: 135-45.
-
(1998)
Int Angiol
, vol.17
, pp. 135-145
-
-
Kirchmaier, C.M.1
Wolf, H.2
Schäfer, H.3
Ehlers, B.4
Breddin, H.K.5
-
6
-
-
0034020857
-
Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis
-
Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV and the EASTERN Investigators. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. Thromb Haemost 2000; 83: 652-6.
-
(2000)
Thromb Haemost
, vol.83
, pp. 652-656
-
-
Harenberg, J.1
Schmidt, J.A.2
Koppenhagen, K.3
Tolle, A.4
Huisman, M.V.5
-
7
-
-
0034776652
-
Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low-molecular-weight heparin certoparin
-
Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low-molecular-weight heparin certoparin. Semin Thromb Hemost 2001; 27: 513-8.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 513-518
-
-
Harenberg, J.1
Huisman, M.V.2
Tolle, A.R.3
Breddin, H.K.4
Kirchmaier, C.M.5
-
8
-
-
0028619850
-
Evaluation of experiments with adaptive interim analyses
-
Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-41.
-
(1994)
Biometrics
, vol.50
, pp. 1029-1041
-
-
Bauer, P.1
Köhne, K.2
-
9
-
-
0020308864
-
Proving the null hypothesis in clinical trials
-
Blackwelder WC. Proving the null hypothesis in clinical trials. Control Clin Trials 1982; 3: 345-53.
-
(1982)
Control Clin Trials
, vol.3
, pp. 345-353
-
-
Blackwelder, W.C.1
-
10
-
-
0021323563
-
Repeated confidence intervals for group sequential clinical trials
-
Jennison C, Turnbull BW. Repeated confidence intervals for group sequential clinical trials. Control Clin Trials 1984; 5: 33-45.
-
(1984)
Control Clin Trials
, vol.5
, pp. 33-45
-
-
Jennison, C.1
Turnbull, B.W.2
-
11
-
-
0032505019
-
Low-molecular-weight heparins: Pharmacologic profile and product differentiation
-
Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Low-molecular-weight heparins: Pharmacologic profile and product differentiation. Am J Cardiol 1998; 82: 3L-10L.
-
(1998)
Am J Cardiol
, vol.82
-
-
Fareed, J.1
Jeske, W.2
Hoppensteadt, D.3
Clarizio, R.4
Walenga, J.M.5
-
12
-
-
0034667833
-
For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same?
-
Van Der Heijden JF, Prins MH, Büller HR. For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same? Thromb Res 2000; 100: V121-V30.
-
(2000)
Thromb Res
, vol.100
-
-
Van Der Heijden, J.F.1
Prins, M.H.2
Büller, H.R.3
-
13
-
-
0034667831
-
Low molecular weight heparins: Are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis
-
Boneu B. Low molecular weight heparins: Are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis. Thromb Res 2000, 100: 113-20.
-
(2000)
Thromb Res
, vol.100
, pp. 113-120
-
-
Boneu, B.1
-
14
-
-
0034707685
-
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism
-
Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000, 160: 181-8.
-
(2000)
Arch Intern Med
, vol.160
, pp. 181-188
-
-
Dolovich, L.R.1
Ginsberg, J.S.2
Douketis, J.D.3
Holbrook, A.M.4
Cheah, G.5
-
15
-
-
0033790854
-
Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis
-
Rocha E, Martinez-Gonzalez MA, Montes R, Panizo C. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica 2000; 85: 935-42.
-
(2000)
Haematologica
, vol.85
, pp. 935-942
-
-
Rocha, E.1
Martinez-Gonzalez, M.A.2
Montes, R.3
Panizo, C.4
-
16
-
-
84921431248
-
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
-
Van Den Belt AGM, Prins MH, Lensing AWA, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Library Syst Rev 2000; 1: 1-18.
-
(2000)
Cochrane Library Syst Rev
, vol.1
, pp. 1-18
-
-
Van Den Belt, A.G.M.1
Prins, M.H.2
Lensing, A.W.A.3
-
17
-
-
0035283104
-
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
-
Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV for the CORTES Investigators. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001; 344: 626-31.
-
(2001)
N Engl J Med
, vol.344
, pp. 626-631
-
-
Breddin, H.K.1
Hach-Wunderle, V.2
Nakov, R.3
Kakkar, V.V.4
-
18
-
-
0033610234
-
Recurrent venous thrombosis and heparin therapy: An evaluation of the importance of early activated partial thromboplastin times
-
Anand SS, Bates S, Ginsberg JS, et al. Recurrent venous thrombosis and heparin therapy: An evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med 1999; 159: 2029-32.
-
(1999)
Arch Intern Med
, vol.159
, pp. 2029-2032
-
-
Anand, S.S.1
Bates, S.2
Ginsberg, J.S.3
-
19
-
-
0026631285
-
The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model
-
Bacher P, Welzel D, Iqbal O, et al. The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model. Thromb Res 1992; 66: 151-8.
-
(1992)
Thromb Res
, vol.66
, pp. 151-158
-
-
Bacher, P.1
Welzel, D.2
Iqbal, O.3
-
20
-
-
0028267616
-
Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin. Results of a pilot study
-
Kirchmaier CM, Lindhoff-Last E, Rübesam D, et al. Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin. Results of a pilot study. Thromb Res 1994; 73: 337-48.
-
(1994)
Thromb Res
, vol.73
, pp. 337-348
-
-
Kirchmaier, C.M.1
Lindhoff-Last, E.2
Rübesam, D.3
-
21
-
-
0029842386
-
Once-daily subcutaneous Dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis
-
Fiessinger JN, Lopez-Fernandez M, Gatterer E, et al. Once-daily subcutaneous Dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thromb Haemost 1996; 76: 195-9.
-
(1996)
Thromb Haemost
, vol.76
, pp. 195-199
-
-
Fiessinger, J.N.1
Lopez-Fernandez, M.2
Gatterer, E.3
-
22
-
-
0031955043
-
Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis
-
Charbonnier BA, Fiessinger J-N, Banga JD, Wenzel E, D'Azemar P, Sagnard L. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. Thromb Haemost 1998, 79: 897-901.
-
(1998)
Thromb Haemost
, vol.79
, pp. 897-901
-
-
Charbonnier, B.A.1
Fiessinger, J.-N.2
Banga, J.D.3
Wenzel, E.4
D'Azemar, P.5
Sagnard, L.6
-
23
-
-
0035814834
-
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
-
Merli G, Spiro TE, Olsson C-G, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001; 134: 191-202.
-
(2001)
Ann Intern Med
, vol.134
, pp. 191-202
-
-
Merli, G.1
Spiro, T.E.2
Olsson, C.-G.3
-
24
-
-
0034756458
-
Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism. A meta-analysis
-
Couturaud F, Julian JA, Kearon C. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism. A meta-analysis. Thromb Haemost 2001, 86: 980-4.
-
(2001)
Thromb Haemost
, vol.86
, pp. 980-984
-
-
Couturaud, F.1
Julian, J.A.2
Kearon, C.3
|